"cancer therapeutic" trang 14 - tải miễn phí từ tailieunhanh
An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma

An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma
10    82    1
Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days

Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days
10    52    1
Psoralen alleviates high glucose-induced HK-2 cell injury by inhibition of Smad 2 signaling via upregulation of microRNA 874

Psoralen alleviates high glucose-induced HK-2 cell injury by inhibition of Smad 2 signaling via upregulation of microRNA 874
10    34    1
Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway

Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway
13    36    1
Development of a computational promoter with highly efficient expression in tumors

Development of a computational promoter with highly efficient expression in tumors
15    25    1
Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels

Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels
3    24    1
Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells

Porcine circovirus type 2 ORF3 protein induces apoptosis in melanoma cells
12    44    1
Management of uterine sarcomas and prognostic indicators: Real world data from a single-institution

Management of uterine sarcomas and prognostic indicators: Real world data from a single-institution
8    62    1
MicroRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells

MicroRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells
10    38    1
First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers

First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: Preliminary results of safety, durable survival and immune biomarkers
11    37    2
Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: Case report and review of the literature on diagnostics standards and therapeutic options

Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: Case report and review of the literature on diagnostics standards and therapeutic options
6    56    1
The germline variants in DNA repair genes in pediatric medulloblastoma: A challenge for current therapeutic strategies

The germline variants in DNA repair genes in pediatric medulloblastoma: A challenge for current therapeutic strategies
11    86    1
The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells

The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells
10    42    1
Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901

Inhibition of glioblastoma dispersal by the MEK inhibitor PD0325901
11    55    1
Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway

Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway
11    40    1
Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target

Disruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target
12    57    1
Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention

Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention
6    50    1
Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: A meta-analysis

Survival, recurrence and toxicity of HNSCC in comparison of a radiotherapy combination with cisplatin versus cetuximab: A meta-analysis
16    41    1
The REFRACT-LYMA cohort study: A French observational prospective cohort study of patients with mantle cell lymphoma

The REFRACT-LYMA cohort study: A French observational prospective cohort study of patients with mantle cell lymphoma
8    41    1
Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
9    42    1